Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Registry (BioSTaR) Including Demographic and Clinical Data of Patients Diagnosed With Rheumatoid Arthritis and Spondyloarthritis Using a Biological and Targeted Synthetic Disease Modifying Drug

NCT04139954 is registered in ClinicalTrials.gov with Turkish League Against Rheumatism as lead sponsor.

NCT NCT04139954
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04139954 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Registry (BioSTaR) Including Demographic and Clinical Data of Patients Diagnosed With Rheumatoid Arthritis and Spondyloarthritis Using a Biological and Targeted Synthetic Disease Modifying Drug
Lead sponsor
Turkish League Against Rheumatism
Phase
Observational
Overall status
Unknown status
Start date
February 1, 2019
Completion date
March 1, 2024
Enrollment
1,400 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis, spondyloarthritis